Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • OMICSEDGE FORMS STRATEGIC PARTNERSHIP WITH ALMADEN GENOMICS TO STREAMLINE DRUG DISCOVERY

    May 19, 2023, 14:00 PM by
    OmicsEdge has launched an industry leading drug discovery service that leverages Almaden’s g.nome™ platform to streamline the iteration process. The service makes it easy for labs to conduct a quick analysis of a patient or trial participant’s medical condition and genomics, gaining valuable insight in genomic criteria and how it affects elevated risk. It can be used to significantly accelerate the drug discovery process and eliminate trial-and-error with abilities such as identifying causal variants that make ideal drug targets.
    Full story
  • New Antimicrobial Susceptibility Test Suggests Generic Z-Pak Can Cure Superbugs

    May 18, 2023, 01:00 AM by User Not Found
    Bio-IT World | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs.
    Full story
  • Variation In The Gut Highlights Human Individuality

    May 16, 2023, 01:00 AM by User Not Found
    Bio-IT World | Anatomical investigations performed on 45 individuals who donated their bodies to science have revealed that the human gut is stunningly diverse based on the size of the organs making up the gastrointestinal (GI) system. Whether those differences are based on what people eat, where they live, or their ancestry is anyone’s guess.
    Full story
  • New Course Provides Expert Insights on AI Disease Modeling and Target Discovery

    May 12, 2023, 16:29 PM by
    Generative artificial intelligence (AI)-driven drug discovery company Insilico Medicine is offering a new, free online course on Disease Modeling and Target Identification. Designed for a broad audience that includes researchers, scientists, pharmaceutical professionals, and students, the course provides lessons from leading experts at Insilico, including biologists, application scientists, and bioinformaticians.
    Full story
  • PEGS Week 2023: Creative Biolabs Unveils the Agenda

    May 12, 2023, 14:51 PM by
    Creative Biolabs is ready for the PEGS Boston Summit, which will exhibit at booth 205 from May 15–19.
    Full story
  • PharmaVigil Automates PV Literature Activities with PubHive

    May 12, 2023, 14:51 PM by
    European Consulting and Safety Services Provider Adopts PubHive’s Validated Drug Safety and Pharmacovigilance Software Platform to Automate Literature Surveillance and Screening
    Full story
  • Alfa Chemistry’s Journey at Pittcon 2023 and ACS Spring 2023 Has Come to a Fruitful and Joyful End

    May 12, 2023, 14:51 PM by
    Alfa Chemistry, a leading provider of analytical chemistry services, has successfully concluded its participation in two major industry events—Pittcon 2023 and the ACS Spring 2023 meetings. The events offered a unique opportunity for the company to showcase its services, connect with industry experts, and stay up to date with the latest advances in the field of analytical chemistry.
    Full story
  • Stable-Isotope Labeling: A Valuable Tool for Researchers Across Various Fields

    May 12, 2023, 14:51 PM by
    Stable-isotope labeling is a powerful tool widely used in most MS-based assays to investigate the topology and operation of metabolic networks. In such cases, accurate quantification is often required. As a supplier of nearly all kinds of chemicals and materials, Alfa Chemistry not only offer thousands of highly valued D, 13C, 15N, 18O, 34S labeled compounds, but also provide a series of stable isotope related technical services, including CSIA, SILAC, SIP, and SIA, for researchers both at home and abroad.
    Full story
  • CD Biosciences Provides Effective Microinjection Services to Accelerate Gene Editing Research

    May 12, 2023, 14:51 PM by
    Full story
  • CD Biosciences Established An Automated System for The Identification of Potential Pro-longevity Compounds

    May 12, 2023, 14:51 PM by
    Full story
  • BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate

    May 12, 2023, 14:51 PM by
    BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production.
    Full story
  • Revolutionizing Animal Healthcare: The Advantages and Applications of Veterinary Rapid Diagnostic Tests

    May 12, 2023, 14:51 PM by
    Veterinary Rapid Diagnostic Tests Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025
    Full story
  • Amerigo Scientific Unveils 1Step RT PCR Kit to Support RNA Studies and Simply Workflow

    May 12, 2023, 14:51 PM by
    Amerigo Scientific unveils 1Step RT PCR Kit for the scientific use of gene-expression analysis, transfection analysis, cDNA cloning, multiplex RT-PCR, etc.
    Full story
  • Endor Labs Recognized As a 2023 Bay Area Best Place to Work

    May 12, 2023, 14:51 PM by
    Endor Labs, an innovative startup securing open source software and the software supply chain, has been named a San Francisco Bay Area Best Place to Work by the San Francisco Business Times and Silicon Valley Business Journal: https://www.bizjournals.com/sanfrancisco/subscriber-only/2023/05/05/best-places-to-work-in-the-bay-area-25-49-employees.html
    Full story
  • Cotiviti Client Conference Brings Together Leading Payer Executives and Experts to Enable a High-Quality and Viable Healthcare System

    May 12, 2023, 14:51 PM by
    CEO Emad Rizk, M.D. to deliver keynote on strategies to bolster payment integrity, harness emerging technology, and foster member engagement
    Full story
  • TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog

    May 12, 2023, 14:51 PM by
    Newest cap analog product improves mRNA potency with greater protein expression, offers time and cost savings, and streamlines manufacturing to drive critical therapeutic and vaccine development
    Full story
  • Verana Health Research on Missing Data for Diabetic Retinopathy Severity Published in the Journal of the American Medical Informatics Association

    May 12, 2023, 14:51 PM by
    Verana Health Research on Missing Data for Diabetic Retinopathy Severity Published in the Journal of the American Medical Informatics Association
    Full story
  • BRIM plans to launch a new funding round to accelerate late-stage clinical trial and initiate a new phase 2 trial for orphan drug BRM424 in the U.S

    May 12, 2023, 14:51 PM by
    BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) announced today that the Board of Directors has approved a seasoned equity offering that will issue 20 to 22.5 million shares of new stocks priced at 60-80 New Taiwan Dollars (~USD 2-2.67) per share.
    Full story
  • The Growing Demand for Disposable Plastic Blood Bags: An Overview of the Market

    May 12, 2023, 14:51 PM by
    Full story
  • Tesis Biosciences Announces New Test That Can Identify Those in Most Danger from Covid-19

    May 12, 2023, 14:51 PM by
    Tesis Biosciences, the leader in targeted genetic sequencing, has developed a new test that identifies the genetic mutations that puts people in the greatest danger from the Covid-19 virus.
    Full story
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88 (current)
  • 89
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy